{
  "meta": {
    "title": "15_Metabolic_Disorders_Of_Urea_Cycle_Complex_Molecules_And_Carbohydrates",
    "url": "https://brainandscalpel.vercel.app/15-metabolic-disorders-of-urea-cycle-complex-molecules-and-carbohydrates-235f7bd2.html",
    "scrapedAt": "2025-11-30T12:33:03.144Z"
  },
  "questions": [
    {
      "text": "A 3-day-old child is suspected to have an inborn error of metabolism. Further evaluation reveals elevated blood ammonia in the presence of normal blood pH and bicarbonate levels. There are no ketone bodies in the urine. Which of the following is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Organic aciduria"
        },
        {
          "id": 2,
          "text": "Disorders of amino acid metabolism"
        },
        {
          "id": 3,
          "text": "Urea cycle defect"
        },
        {
          "id": 4,
          "text": "Galactosemia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In this case, <strong>hyperammonemia is&nbsp;+ve; acidosis is -ve; and ketosis is -ve:</strong>&nbsp;This is consistent with the&nbsp;<strong>u</strong><strong>rea cycle defect</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/dd152bb0a72e4cd2810eeaa55a5443a1x1280x2560.0.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7653",
      "difficulty": "medium"
    },
    {
      "text": "A young infant started seizing in his cradle. He was immediately rushed to the casualty. On investigation, blood ammonia was markedly elevated. Which of the following is used to lower the ammonia levels?",
      "choices": [
        {
          "id": 1,
          "text": "Sodium benzoate"
        },
        {
          "id": 2,
          "text": "Sodium phenylacetate"
        },
        {
          "id": 3,
          "text": "Arginine hydrochloride"
        },
        {
          "id": 4,
          "text": "All of the above"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>All of the above agents are used in the treatment of acute hyperammonemia in an infant.</p>\n<p>Treatment of&nbsp;acute hyperammonemia in an infant:</p>\n<ul>\n<li>Provide <strong>adequate calories, fluid, and electrolytes</strong> intravenously.</li>\n<li><strong>Minimal amounts of protein</strong> as a mixture of <strong>essential amino acids</strong> during the first&nbsp;24 hours of therapy.</li>\n<li>Give <strong>priming doses</strong> of the following compounds:&nbsp;<strong>Sodium benzoate,&nbsp;Sodium phenylacetate,&nbsp;Arginine hydrochloride</strong>.</li>\n<li>Initiate <strong>peritoneal dialysis or hemodialysis</strong> if the <strong>above treatment fails</strong> to produce an appreciable decrease in plasma ammonia levels.</li>\n</ul>\n<p><strong>Benzoate</strong> forms <strong>hippurate</strong> with endogenous glycine in the liver. Each mole of benzoate removes 1 mole of ammonia as glycine.</p>\n<p><strong> Phenylacetate</strong> conjugates with glutamine to form <strong>phenylacetylglutamine</strong>, which is readily excreted in the urine. One mole of phenylacetate removes 2 moles of ammonia as glutamine from the body.</p>\n<p><strong>Arginine</strong> administration supplies the urea cycle with <strong>ornithine.</strong> It is effective in all patients, except those with arginase deficiency.</p>\n<p><strong>Note: </strong></p>\n<p><strong>Phenylbutyrate</strong> which is metabolized to phenylacetate in our body can also be used as it <strong>scavenges nitrogen.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7836",
      "difficulty": "easy"
    },
    {
      "text": "An infant's mother is distressed that her baby refuses her feeds and starts vomiting immediately when fed and becomes lethargic. After thorough investigations, the baby is diagnosed with HHH syndrome. Which of the following is least likely to be found?",
      "choices": [
        {
          "id": 1,
          "text": "Hyperuricemia"
        },
        {
          "id": 2,
          "text": "Hyperammonemia"
        },
        {
          "id": 3,
          "text": "Hyperornithinemia"
        },
        {
          "id": 4,
          "text": "Homocitrullinemia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Hyperuricemia</strong>&nbsp;is<strong> not</strong> a component of HHH syndrome</p>\n<p><strong>HHH syndrome&nbsp;</strong>is a rare<strong> autosomal-recessive disorder</strong> caused by a defect in the transport system of ornithine from the cytosol into the mitochondria (<strong>deficiency of ornithine permease/translocase),</strong>&nbsp;resulting in the accumulation of ornithine in the cytosol leading to hyperornithinemia and a deficiency of this amino acid in mitochondria&nbsp;results in the disruption of the urea cycle and hyperammonemia. Homocitrulline is formed from the reaction of mitochondrial carbamyl phosphate with lysine, which can become a substrate for the OTC reaction when ornithine is deficient.</p>\n<p>Components of HHH syndrome:</p>\n<ul>\n<li>Hyperammonemia</li>\n<li>Hyperornithinemia</li>\n<li>Homocitrullinemia</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7835",
      "difficulty": "medium"
    },
    {
      "text": "As a geneticist studying the familial inheritance of porphyrias, which of the following is likely to show the inheritance pattern given below?",
      "choices": [
        {
          "id": 1,
          "text": "Congenital erythropoietic porphyria"
        },
        {
          "id": 2,
          "text": "Variegate porphyria"
        },
        {
          "id": 3,
          "text": "δ-Aminolevulinic acid dehydratase porphyria"
        },
        {
          "id": 4,
          "text": "X-linked protoporphyria"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given pedigree chart shows <strong>X-linked dominant inheritance</strong>. <strong>X-linked protoporphyria</strong> is inherited in an X-linked dominant pattern.</p><p>All porphyrias are autosomal dominant except the following :</p>\n<ul>\n<li>Congenital erythropoietic porphyria (CEP) (<strong>autosomal recessive</strong>)</li>\n<li>&delta;-Aminolevulinic acid dehydratase porphyria (ADP) (<strong>autosomal recessive</strong>)</li>\n<li>Protoporphyria - X-linked protoporphyria (<strong>X-linked dominant</strong>)&nbsp;</li>\n<li>Erythropoietic protoporphyria (EPP)&nbsp;(<strong>autosomal recessive</strong>)</li>\n</ul><hr><h3>Related Pearl: Types of porphyria</h3><p>Clinically porphyrias can be classified into:</p>\n<ul>\n<li>Hepatic porphyria: The overproduction of heme pathway intermediates occurs primarily in the liver.</li>\n<li>Erythropoietic porphyria: The overproduction of heme pathway intermediates occurs primarily in bone marrow erythroid cells.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2370f6a3e9e64db5b0d342d7fc4a410fx1280x1964.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Porphyria type</strong></span></div>\n</td>\n<td>\n<div><span><strong>Deficient </strong> <strong>enzyme</strong></span></div>\n</td>\n<td>\n<div><span><strong>Lab findings</strong></span></div>\n</td>\n<td> </td>\n<td>\n<div><span><strong>Symptoms</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>X-linked dominant protoporphyria</span></div>\n<div><span>(XLDPP)</span></div>\n</td>\n<td>\n<div><span>δ-aminolevulinate synthase 2</span></div>\n<div><span>(ALAS - 2)</span></div>\n</td>\n<td><span>Decreased RBC count and hemoglobin</span></td>\n<td>\n<div><span>Cutaneous photosensitivity</span></div>\n</td>\n<td>\n<div><span>Photosensitivity</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Aminolevulinate dehydratase deficiency porphyria</span></div>\n<div><span>(ALADP)</span></div>\n</td>\n<td>\n<div><span>δ-aminolevulinate dehydratase</span></div>\n<div><span>(ALAD)</span></div>\n</td>\n<td><span>Increased urinary ALA and coproporphyrin III </span></td>\n<td><span>Neurovisceral symptoms</span></td>\n<td>\n<div><span>Abdominal pain, neuropathy</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Acute intermittent porphyria</span></div>\n<div><span>(AIP)</span></div>\n</td>\n<td>\n<div><span>Hydroxymethylbilane synthase</span></div>\n<div><span>(Uroporphyrin I synthase)</span></div>\n</td>\n<td><span>Increased urinary ALA and PBG </span></td>\n<td><span>Neurovisceral symptoms </span></td>\n<td>\n<div><span>Periodic abdominal pain, peripheral neuropathy, psychiatric symptoms, tachycardia</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Congenital Erythropoietic porphyria</span></div>\n<div><span>(CEP)</span></div>\n</td>\n<td>\n<div><span>Uroporphyrinogen III synthase</span></div>\n<div><span>(UROS)</span></div>\n</td>\n<td><span>Increased urinary, fecal and red cell uroporphyrin I</span></td>\n<td><span>Cutaneous photosensitivity</span></td>\n<td>\n<div><span>Severe photosensitivity with erythema, swelling and blistering, hemolytic anemia, splenomegaly</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Porphyria cutanea tarda (PCT)</span></div>\n</td>\n<td>\n<div><span>Uroporphyrinogen decarboxylase</span></div>\n<div><span>(UROD)</span></div>\n</td>\n<td><span>Increased uroporphyrin I</span></td>\n<td><span> </span>\n<div><span>Cutaneous photosensitivity</span></div>\n</td>\n<td>\n<div><span>Photosensitivity with vesicles and bullae</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Hereditary coproporphyria</span></div>\n<div><span>(HCP)</span></div>\n</td>\n<td>\n<div><span>Coproporphyrinogen oxidase</span></div>\n<div><span>(CPOX)</span></div>\n</td>\n<td><span>Increased urinary ALA, PBG, and coproporphyrin III and fecal coproporphyrin III</span></td>\n<td><span>Both</span></td>\n<td>\n<div><span>Photosensitivity, neurologic symptoms, abdominal colic</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Variegate porphyria</span></div>\n<div><span>(VP)</span></div>\n</td>\n<td>\n<div><span>Protoporphyrinogen oxidase</span></div>\n<div><span>(PPOX)</span></div>\n</td>\n<td><span>Increased urinary ALA, PBG, and coproporphyrin III and fecal protoporphyrin IX</span></td>\n<td><span>Both</span></td>\n<td>\n<div><span>Photosensitivity, neurologic symptoms, developmental delay</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Erythropoietic protoporphyria</span></div>\n<div><span>(EPP)</span></div>\n</td>\n<td>\n<div><span>Ferrochelatase</span></div>\n<div><span>(FECH)</span></div>\n</td>\n<td><span>Increased fecal and red cell protoporphyrin IX </span></td>\n<td><span>Cutaneous photosensitivity</span></td>\n<td>\n<div><span>Non-blistering Photosensitivity with skin lesions</span></div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<div><span> </span></div>\n<div><span>Most porphyrias are <strong>autosomal dominant</strong> <strong>except:</strong></span></div>\n<div>\n<ul>\n<li><span>ALAD enzyme deficiency porphyria</span></li>\n<li><span>Congenital erythropoietic porphyria</span></li>\n<li><span>Erythropoietic protoporphyria</span></li>\n<li><span>X-linked protoporphyria</span></li>\n</ul>\n</div><hr><h3>Related Pearl: Pedigree chart for different inheritance patterns</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b04518e36bdd471daf76691dafd74139x1280x2969.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/195c2ef3907e4d8eac2c909799cbef3ex1280x2742.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/73550cf2ed6549049b75a4c640016a05.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7662",
      "difficulty": "medium"
    },
    {
      "text": "The most common porphyria which manifests in childhood is ______",
      "choices": [
        {
          "id": 1,
          "text": "Porphyria cutanea tarda"
        },
        {
          "id": 2,
          "text": "Congenital erythropoietic porphyria"
        },
        {
          "id": 3,
          "text": "Erythropoietic protoporphyria"
        },
        {
          "id": 4,
          "text": "Hereditary coproporphyria"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Erythropoietic protoporphyria</strong> (autosomal recessive) is the <strong>most common porphyria</strong> to manifest in childhood.</p>\n<p>Porphyria cutanea tarda (option A) manifests in adults.</p>\n<p>Congenital erythropoietic porphyria (option B) also known as G&uuml;nther disease presents itself in utero or in infancy. It is a rare autosomal-recessive disease.</p>\n<p>Hereditary coproporphyria (option D) presents itself in the post-pubertal age.</p><hr><h3>Related Pearl: Types of porphyria</h3><p>Clinically porphyrias can be classified into:</p>\n<ul>\n<li>Hepatic porphyria: The overproduction of heme pathway intermediates occurs primarily in the liver.</li>\n<li>Erythropoietic porphyria: The overproduction of heme pathway intermediates occurs primarily in bone marrow erythroid cells.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2370f6a3e9e64db5b0d342d7fc4a410fx1280x1964.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Porphyria type</strong></span></div>\n</td>\n<td>\n<div><span><strong>Deficient </strong> <strong>enzyme</strong></span></div>\n</td>\n<td>\n<div><span><strong>Lab findings</strong></span></div>\n</td>\n<td> </td>\n<td>\n<div><span><strong>Symptoms</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>X-linked dominant protoporphyria</span></div>\n<div><span>(XLDPP)</span></div>\n</td>\n<td>\n<div><span>δ-aminolevulinate synthase 2</span></div>\n<div><span>(ALAS - 2)</span></div>\n</td>\n<td><span>Decreased RBC count and hemoglobin</span></td>\n<td>\n<div><span>Cutaneous photosensitivity</span></div>\n</td>\n<td>\n<div><span>Photosensitivity</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Aminolevulinate dehydratase deficiency porphyria</span></div>\n<div><span>(ALADP)</span></div>\n</td>\n<td>\n<div><span>δ-aminolevulinate dehydratase</span></div>\n<div><span>(ALAD)</span></div>\n</td>\n<td><span>Increased urinary ALA and coproporphyrin III </span></td>\n<td><span>Neurovisceral symptoms</span></td>\n<td>\n<div><span>Abdominal pain, neuropathy</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Acute intermittent porphyria</span></div>\n<div><span>(AIP)</span></div>\n</td>\n<td>\n<div><span>Hydroxymethylbilane synthase</span></div>\n<div><span>(Uroporphyrin I synthase)</span></div>\n</td>\n<td><span>Increased urinary ALA and PBG </span></td>\n<td><span>Neurovisceral symptoms </span></td>\n<td>\n<div><span>Periodic abdominal pain, peripheral neuropathy, psychiatric symptoms, tachycardia</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Congenital Erythropoietic porphyria</span></div>\n<div><span>(CEP)</span></div>\n</td>\n<td>\n<div><span>Uroporphyrinogen III synthase</span></div>\n<div><span>(UROS)</span></div>\n</td>\n<td><span>Increased urinary, fecal and red cell uroporphyrin I</span></td>\n<td><span>Cutaneous photosensitivity</span></td>\n<td>\n<div><span>Severe photosensitivity with erythema, swelling and blistering, hemolytic anemia, splenomegaly</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Porphyria cutanea tarda (PCT)</span></div>\n</td>\n<td>\n<div><span>Uroporphyrinogen decarboxylase</span></div>\n<div><span>(UROD)</span></div>\n</td>\n<td><span>Increased uroporphyrin I</span></td>\n<td><span> </span>\n<div><span>Cutaneous photosensitivity</span></div>\n</td>\n<td>\n<div><span>Photosensitivity with vesicles and bullae</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Hereditary coproporphyria</span></div>\n<div><span>(HCP)</span></div>\n</td>\n<td>\n<div><span>Coproporphyrinogen oxidase</span></div>\n<div><span>(CPOX)</span></div>\n</td>\n<td><span>Increased urinary ALA, PBG, and coproporphyrin III and fecal coproporphyrin III</span></td>\n<td><span>Both</span></td>\n<td>\n<div><span>Photosensitivity, neurologic symptoms, abdominal colic</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Variegate porphyria</span></div>\n<div><span>(VP)</span></div>\n</td>\n<td>\n<div><span>Protoporphyrinogen oxidase</span></div>\n<div><span>(PPOX)</span></div>\n</td>\n<td><span>Increased urinary ALA, PBG, and coproporphyrin III and fecal protoporphyrin IX</span></td>\n<td><span>Both</span></td>\n<td>\n<div><span>Photosensitivity, neurologic symptoms, developmental delay</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Erythropoietic protoporphyria</span></div>\n<div><span>(EPP)</span></div>\n</td>\n<td>\n<div><span>Ferrochelatase</span></div>\n<div><span>(FECH)</span></div>\n</td>\n<td><span>Increased fecal and red cell protoporphyrin IX </span></td>\n<td><span>Cutaneous photosensitivity</span></td>\n<td>\n<div><span>Non-blistering Photosensitivity with skin lesions</span></div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<div><span> </span></div>\n<div><span>Most porphyrias are <strong>autosomal dominant</strong> <strong>except:</strong></span></div>\n<div>\n<ul>\n<li><span>ALAD enzyme deficiency porphyria</span></li>\n<li><span>Congenital erythropoietic porphyria</span></li>\n<li><span>Erythropoietic protoporphyria</span></li>\n<li><span>X-linked protoporphyria</span></li>\n</ul>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7668",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following is also known as plumboporphyria due to its clinical similarity to lead poisoning?",
      "choices": [
        {
          "id": 1,
          "text": "Acute intermittent porphyria (AIP)"
        },
        {
          "id": 2,
          "text": "δ-Aminolevulinic acid dehydratase porphyria (ALAD)"
        },
        {
          "id": 3,
          "text": "Porphyria cutanea tarda (PCT)"
        },
        {
          "id": 4,
          "text": "Erythropoietic protoporphyria (EPP)"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>&delta;-Aminolevulinic acid dehydratase porphyria (ALAD)&nbsp;is also called <strong>plumboporphyria</strong>/Doss porphyria due to its clinical similarity to lead poisoning, although it is not related to lead exposure.</p>\n<p>ALAD catalyzes the condensation of 2 molecules of ALA to form the pyrrole porphobilinogen (PBG). The enzyme is subject to inhibition by lead because ALAD is the principal lead-binding protein in erythrocytes, and lead can displace the zinc atoms of the enzyme, thus inhibiting it. Therefore, both lead poisoning and ALAD porphyria produce similar signs and symptoms.&nbsp;Symptoms resemble those of other acute porphyrias, including acute attacks of abdominal pain and neuropathy.</p><hr><h3>Related Pearl: Types of porphyria</h3><p>Clinically porphyrias can be classified into:</p>\n<ul>\n<li>Hepatic porphyria: The overproduction of heme pathway intermediates occurs primarily in the liver.</li>\n<li>Erythropoietic porphyria: The overproduction of heme pathway intermediates occurs primarily in bone marrow erythroid cells.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2370f6a3e9e64db5b0d342d7fc4a410fx1280x1964.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Porphyria type</strong></span></div>\n</td>\n<td>\n<div><span><strong>Deficient </strong> <strong>enzyme</strong></span></div>\n</td>\n<td>\n<div><span><strong>Lab findings</strong></span></div>\n</td>\n<td> </td>\n<td>\n<div><span><strong>Symptoms</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>X-linked dominant protoporphyria</span></div>\n<div><span>(XLDPP)</span></div>\n</td>\n<td>\n<div><span>δ-aminolevulinate synthase 2</span></div>\n<div><span>(ALAS - 2)</span></div>\n</td>\n<td><span>Decreased RBC count and hemoglobin</span></td>\n<td>\n<div><span>Cutaneous photosensitivity</span></div>\n</td>\n<td>\n<div><span>Photosensitivity</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Aminolevulinate dehydratase deficiency porphyria</span></div>\n<div><span>(ALADP)</span></div>\n</td>\n<td>\n<div><span>δ-aminolevulinate dehydratase</span></div>\n<div><span>(ALAD)</span></div>\n</td>\n<td><span>Increased urinary ALA and coproporphyrin III </span></td>\n<td><span>Neurovisceral symptoms</span></td>\n<td>\n<div><span>Abdominal pain, neuropathy</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Acute intermittent porphyria</span></div>\n<div><span>(AIP)</span></div>\n</td>\n<td>\n<div><span>Hydroxymethylbilane synthase</span></div>\n<div><span>(Uroporphyrin I synthase)</span></div>\n</td>\n<td><span>Increased urinary ALA and PBG </span></td>\n<td><span>Neurovisceral symptoms </span></td>\n<td>\n<div><span>Periodic abdominal pain, peripheral neuropathy, psychiatric symptoms, tachycardia</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Congenital Erythropoietic porphyria</span></div>\n<div><span>(CEP)</span></div>\n</td>\n<td>\n<div><span>Uroporphyrinogen III synthase</span></div>\n<div><span>(UROS)</span></div>\n</td>\n<td><span>Increased urinary, fecal and red cell uroporphyrin I</span></td>\n<td><span>Cutaneous photosensitivity</span></td>\n<td>\n<div><span>Severe photosensitivity with erythema, swelling and blistering, hemolytic anemia, splenomegaly</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Porphyria cutanea tarda (PCT)</span></div>\n</td>\n<td>\n<div><span>Uroporphyrinogen decarboxylase</span></div>\n<div><span>(UROD)</span></div>\n</td>\n<td><span>Increased uroporphyrin I</span></td>\n<td><span> </span>\n<div><span>Cutaneous photosensitivity</span></div>\n</td>\n<td>\n<div><span>Photosensitivity with vesicles and bullae</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Hereditary coproporphyria</span></div>\n<div><span>(HCP)</span></div>\n</td>\n<td>\n<div><span>Coproporphyrinogen oxidase</span></div>\n<div><span>(CPOX)</span></div>\n</td>\n<td><span>Increased urinary ALA, PBG, and coproporphyrin III and fecal coproporphyrin III</span></td>\n<td><span>Both</span></td>\n<td>\n<div><span>Photosensitivity, neurologic symptoms, abdominal colic</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Variegate porphyria</span></div>\n<div><span>(VP)</span></div>\n</td>\n<td>\n<div><span>Protoporphyrinogen oxidase</span></div>\n<div><span>(PPOX)</span></div>\n</td>\n<td><span>Increased urinary ALA, PBG, and coproporphyrin III and fecal protoporphyrin IX</span></td>\n<td><span>Both</span></td>\n<td>\n<div><span>Photosensitivity, neurologic symptoms, developmental delay</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Erythropoietic protoporphyria</span></div>\n<div><span>(EPP)</span></div>\n</td>\n<td>\n<div><span>Ferrochelatase</span></div>\n<div><span>(FECH)</span></div>\n</td>\n<td><span>Increased fecal and red cell protoporphyrin IX </span></td>\n<td><span>Cutaneous photosensitivity</span></td>\n<td>\n<div><span>Non-blistering Photosensitivity with skin lesions</span></div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<div><span> </span></div>\n<div><span>Most porphyrias are <strong>autosomal dominant</strong> <strong>except:</strong></span></div>\n<div>\n<ul>\n<li><span>ALAD enzyme deficiency porphyria</span></li>\n<li><span>Congenital erythropoietic porphyria</span></li>\n<li><span>Erythropoietic protoporphyria</span></li>\n<li><span>X-linked protoporphyria</span></li>\n</ul>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7663",
      "difficulty": "medium"
    },
    {
      "text": "A 16-year-old girl was admitted for severe abdominal pain, nausea, vomiting, and diarrhea. She developed generalized seizures in the hospital for which she was given phenytoin. Her symptoms worsened, she developed muscle weakness which progressed to quadriparesis. Urinary porphobilinogen was found to be high. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Congenital erthyropoietic porphyria"
        },
        {
          "id": 2,
          "text": "Porphyria cutanea tarda"
        },
        {
          "id": 3,
          "text": "Acute intermittent porphyria"
        },
        {
          "id": 4,
          "text": "X-linked protoporphyria"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The most likely diagnosis is<strong>&nbsp;acute intermittent porphyria</strong>&nbsp;which presents as a <strong>neurovisceral syndrome</strong> with <strong>no cutaneous manifestations and no phototoxicity.</strong></p>\n<p><strong>Acute Intermittent Porphyria:</strong></p>\n<ul>\n<li>Autosomal dominant</li>\n<li>Deficiency of the enzyme porphobilinogen deaminase</li>\n<li>Presents at post-pubertal age</li>\n<li>Present with hepatic and neurologic manifestations</li>\n<li>Exacerbated by P450 inducing drugs like phenytoin, progesterone and dietary restriction</li>\n</ul><hr><h3>Related Pearl: Human Porphyrias and Their Features</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<div><span><strong>Acute intermittent porphyria</strong></span></div>\n</td>\n<td>\n<div><span><strong>Porphyria cutanea tarda</strong></span></div>\n</td>\n<td>\n<div><span><strong>Erythropoietic protoporphyria</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Presenting symptoms</strong></span></div>\n</td>\n<td>\n<div><span>Neurologic</span></div>\n</td>\n<td>\n<div><span>Chronic skin blistering, fragility</span></div>\n</td>\n<td>\n<div><span>Acute skin swelling, pain</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Onset</strong></span></div>\n</td>\n<td>\n<div><span>Adult-onset</span></div>\n</td>\n<td><span>Adult-onset</span></td>\n<td><span>Childhood-onset</span></td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Exacerbating factors</strong></span></div>\n</td>\n<td>\n<div><span>Drugs (like P450 inducers), progesterone, dietary restriction</span></div>\n</td>\n<td>\n<div><span>Iron, alcohol, smoking, estrogens, hepatitis C, HIV, halogenated hydrocarbons</span></div>\n</td>\n<td>\n<div><span>---</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Most important screening Tests</strong></span></div>\n</td>\n<td>\n<div><span>Urinary porphobilinogen</span></div>\n</td>\n<td>\n<div><span>Plasma (or urine)</span></div>\n<div><span>porphyrins</span></div>\n</td>\n<td>\n<div><span>Erythrocyte (or plasma) porphyrins</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Treatment</strong></span></div>\n</td>\n<td>\n<div><span>Hemin, glucose</span></div>\n</td>\n<td>\n<div><span>Phlebotomy, low-dose hydroxychloroquine</span></div>\n</td>\n<td>\n<div><span>Beta-carotene</span></div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7667",
      "difficulty": "medium"
    },
    {
      "text": "You are reading an article titled, ' Dark age vampires or our patients', which describes an 18-year-old man who has had an intolerance to sunshine since the age of 6. When playing cricket he suffered intense burning, redness, swelling, and crusting of knees unprotected by shorts, with similar changes on cheeks and bridge of the nose. His labs showed elevated concentrations of total erythrocyte protoporphyrin. Which of the following enzyme deficiencies can explain this boy's condition?",
      "choices": [
        {
          "id": 1,
          "text": "δ-Aminolevulinate synthase 2 (ALAS2)"
        },
        {
          "id": 2,
          "text": "δ-Aminolevulinic acid dehydratase (ALAD)"
        },
        {
          "id": 3,
          "text": "Porphobilinogen deaminase (PBGD)"
        },
        {
          "id": 4,
          "text": "Ferrochelatase (FECH)"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Symptoms of<strong> cutaneous photosensitivity</strong> beginning in childhood and&nbsp;a substantially<strong> elevated concentration of total erythrocyte protoporphyrin</strong> supports a diagnosis of&nbsp;<strong>erythropoietic protoporphyria</strong>. The enzyme deficient in erythropoietic protoporphyria is <strong>ferrochelatase (FECH).</strong></p>\n<p>Symptoms consist of acute pain and itching often occurring within minutes of sunlight exposure and followed by redness and swelling with continued exposure. Swelling may resemble angioneurotic edema and <strong>solar urticaria.</strong> Symptoms are usually worse in&nbsp;the spring and summer. Chronic changes may include lichenification, leathery pseudovesicles, labial grooving, and nail changes, but changes in pigmentation and pronounced scarring are unusual.</p>\n<p>Life-threatening<strong> protoporphyric hepatopathy</strong> is characterized by greater increases in erythrocyte and plasma protoporphyrin levels, increased photosensitivity, and either chronically abnormal liver function tests or rapidly progressive hepatic failure.</p><p><strong>Afamelanotide,</strong>&nbsp;a synthetic analogue of the alpha-melanocyte-stimulating hormone is&nbsp;recently approved by the FDA for the treatment of&nbsp;<strong>erythropoietic protoporphyria.</strong>&nbsp;The drug acts by increasing sunlight tolerance.</p><hr><h3>Related Pearl: Types of porphyria</h3><p>Clinically porphyrias can be classified into:</p>\n<ul>\n<li>Hepatic porphyria: The overproduction of heme pathway intermediates occurs primarily in the liver.</li>\n<li>Erythropoietic porphyria: The overproduction of heme pathway intermediates occurs primarily in bone marrow erythroid cells.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2370f6a3e9e64db5b0d342d7fc4a410fx1280x1964.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Porphyria type</strong></span></div>\n</td>\n<td>\n<div><span><strong>Deficient </strong> <strong>enzyme</strong></span></div>\n</td>\n<td>\n<div><span><strong>Lab findings</strong></span></div>\n</td>\n<td> </td>\n<td>\n<div><span><strong>Symptoms</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>X-linked dominant protoporphyria</span></div>\n<div><span>(XLDPP)</span></div>\n</td>\n<td>\n<div><span>δ-aminolevulinate synthase 2</span></div>\n<div><span>(ALAS - 2)</span></div>\n</td>\n<td><span>Decreased RBC count and hemoglobin</span></td>\n<td>\n<div><span>Cutaneous photosensitivity</span></div>\n</td>\n<td>\n<div><span>Photosensitivity</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Aminolevulinate dehydratase deficiency porphyria</span></div>\n<div><span>(ALADP)</span></div>\n</td>\n<td>\n<div><span>δ-aminolevulinate dehydratase</span></div>\n<div><span>(ALAD)</span></div>\n</td>\n<td><span>Increased urinary ALA and coproporphyrin III </span></td>\n<td><span>Neurovisceral symptoms</span></td>\n<td>\n<div><span>Abdominal pain, neuropathy</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Acute intermittent porphyria</span></div>\n<div><span>(AIP)</span></div>\n</td>\n<td>\n<div><span>Hydroxymethylbilane synthase</span></div>\n<div><span>(Uroporphyrin I synthase)</span></div>\n</td>\n<td><span>Increased urinary ALA and PBG </span></td>\n<td><span>Neurovisceral symptoms </span></td>\n<td>\n<div><span>Periodic abdominal pain, peripheral neuropathy, psychiatric symptoms, tachycardia</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Congenital Erythropoietic porphyria</span></div>\n<div><span>(CEP)</span></div>\n</td>\n<td>\n<div><span>Uroporphyrinogen III synthase</span></div>\n<div><span>(UROS)</span></div>\n</td>\n<td><span>Increased urinary, fecal and red cell uroporphyrin I</span></td>\n<td><span>Cutaneous photosensitivity</span></td>\n<td>\n<div><span>Severe photosensitivity with erythema, swelling and blistering, hemolytic anemia, splenomegaly</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Porphyria cutanea tarda (PCT)</span></div>\n</td>\n<td>\n<div><span>Uroporphyrinogen decarboxylase</span></div>\n<div><span>(UROD)</span></div>\n</td>\n<td><span>Increased uroporphyrin I</span></td>\n<td><span> </span>\n<div><span>Cutaneous photosensitivity</span></div>\n</td>\n<td>\n<div><span>Photosensitivity with vesicles and bullae</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Hereditary coproporphyria</span></div>\n<div><span>(HCP)</span></div>\n</td>\n<td>\n<div><span>Coproporphyrinogen oxidase</span></div>\n<div><span>(CPOX)</span></div>\n</td>\n<td><span>Increased urinary ALA, PBG, and coproporphyrin III and fecal coproporphyrin III</span></td>\n<td><span>Both</span></td>\n<td>\n<div><span>Photosensitivity, neurologic symptoms, abdominal colic</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Variegate porphyria</span></div>\n<div><span>(VP)</span></div>\n</td>\n<td>\n<div><span>Protoporphyrinogen oxidase</span></div>\n<div><span>(PPOX)</span></div>\n</td>\n<td><span>Increased urinary ALA, PBG, and coproporphyrin III and fecal protoporphyrin IX</span></td>\n<td><span>Both</span></td>\n<td>\n<div><span>Photosensitivity, neurologic symptoms, developmental delay</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Erythropoietic protoporphyria</span></div>\n<div><span>(EPP)</span></div>\n</td>\n<td>\n<div><span>Ferrochelatase</span></div>\n<div><span>(FECH)</span></div>\n</td>\n<td><span>Increased fecal and red cell protoporphyrin IX </span></td>\n<td><span>Cutaneous photosensitivity</span></td>\n<td>\n<div><span>Non-blistering Photosensitivity with skin lesions</span></div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<div><span> </span></div>\n<div><span>Most porphyrias are <strong>autosomal dominant</strong> <strong>except:</strong></span></div>\n<div>\n<ul>\n<li><span>ALAD enzyme deficiency porphyria</span></li>\n<li><span>Congenital erythropoietic porphyria</span></li>\n<li><span>Erythropoietic protoporphyria</span></li>\n<li><span>X-linked protoporphyria</span></li>\n</ul>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7664",
      "difficulty": "medium"
    },
    {
      "text": "A 6-month-old baby boy has coarse facial features, cloudy corneas, and gingival hypertrophy. He has no neck control and is unable to roll over. Laboratory investigations reveal markedly reduced activity of N-acetylglucosaminyl-1-phosphotransferase activity in WBCs. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "I-cell disease"
        },
        {
          "id": 2,
          "text": "Galactosemia"
        },
        {
          "id": 3,
          "text": "Adrenoleukodystrophy"
        },
        {
          "id": 4,
          "text": "Hurler's syndrome"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>This clinical vignette is strongly suggestive of&nbsp;<strong>I-cell disease</strong>&nbsp;or <strong>inclusion cell disease</strong>.&nbsp; It is also known as type&nbsp;II Mucolipidosis.</p>\n<p>It is an<strong> autosomal recessive</strong> inherited as a&nbsp;<strong>lysosomal storage disorder.</strong>&nbsp;It is&nbsp;caused due to a defect in <strong>N-acetylglucosaminyl-1-phosphotransferase</strong> required for the Golgi to phosphorylate mannose residues on glycoproteins. This leads to defective<strong>&nbsp;mannose-6-phosphate,&nbsp;</strong>an&nbsp;important cell signaling molecule&nbsp;required for<strong> trafficking of the lysosomal enzyme</strong> from the site of its production in the endoplasmic reticulum to the lysosome. Due to this defect, the lysosomal enzymes are secreted out of the cell and there is an increased serum concentration of the same. Intracellularly, there are abnormal inclusion bodies and vacuolizations, thus earning the disease its name.</p>\n<p>Clinically, these patients present with symptoms either at birth or early in life with growth retardation, failure to thrive, <strong>delay of developmental milestones, coarse facial features with a cloudy cornea and gingival hypertrophy,</strong> and other non-specific findings such as&nbsp;hip dislocations, inguinal hernias, hepatomegaly, joint limitation, and skin changes.&nbsp;</p>\n<p>Investigations to establish a diagnosis may include measuring&nbsp;N-acetylglucosaminyl-1-phosphotransferase activity in WBCs or in cultured fibroblasts and estimating <strong>serum levels of lysosomal enzymes.</strong></p>\n<p>Option B: <strong>Galactosemia</strong> is caused due to the&nbsp;<span data-preserver-spaces=\"true\">complete <strong>absence of g</strong></span><span data-preserver-spaces=\"true\"><strong>alactose-1-phosphate uridyl transferase</strong>.&nbsp;The deficiency of this enzyme leads to an inability to convert galactose-1-phosphate (galactose-1-P) to uridine diphosphate galactose. It is characterized by t</span><span data-preserver-spaces=\"true\">ypical clinical features such as jaundice, vomiting, hepatomegaly, failure to thrive, poor feeding, lethargy, diarrhea, E.Coli sepsis. Infants may also have edema,&nbsp;ascites, full fontanelle, encephalopathy, and excessive bruising and bleeding. They tend to develop cataracts due to the accumulation of&nbsp;galactitol.</span></p>\n<p>Option C:<strong>&nbsp;Adrenoleukodystrophy</strong>&nbsp;is an <strong>X-linked recessive disorder of &beta;-oxidation of fatty acids</strong>. There is a very large chain fatty acids buildup in the adrenal glands, the white matter of the brain, and testes. It is a progressive disease that can lead to <strong>adrenal gland crisis, coma, and death.</strong></p>\n<p>Option D:&nbsp;<strong>Hurler syndrome</strong> is an important diagnosis in a patient presenting with clinical features given in this clinical vignette. But it is&nbsp;a&nbsp;mucopolysaccharidosis type 1-H&nbsp;caused&nbsp;due by the defect in the&nbsp;&alpha;-L Iduronidase&nbsp;leading to the <strong>accumulation of&nbsp;heparin sulfate and dermatan sulfate.</strong>&nbsp;It is characterized by skeletal abnormalities, hepatosplenomegaly, and severe intellectual disability. Infants develop characteristic coarse facial features, a wide nasal bridge, and a flattened midface. Features such as hepatosplenomegaly,&nbsp;umbilical or inguinal hernias, and typical skeletal abnormalities, known as&nbsp;dysostosis multiplex laos&nbsp;are also seen. They also have developmental delays and recurrent sinopulmonary diseases. Failure to thrive and growth restriction are also seen.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9412",
      "difficulty": "hard"
    },
    {
      "text": "An 8-year-old boy is brought with complaints of severe pain in his right thigh which has progressively worsened over the last few months. He is unable to walk because of the same. His mother also says he has had repeated nose bleeds in the last few months and the child has stopped playing with his friends as he gets easily tired for a month. Physical examination reveals hepatosplenomegaly. Lab reports show thrombocytopenia and anemia. An assay of peripheral blood leucocytes shows low levels of beta-glucosidase. What is the inheritance pattern of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "X-linked recessive"
        },
        {
          "id": 2,
          "text": "X-linked dominant"
        },
        {
          "id": 3,
          "text": "Autosomal recessive"
        },
        {
          "id": 4,
          "text": "Autosomal dominant"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario of bone pain, epistaxis, hepatosplenomegaly, and low levels of&nbsp;&beta;-glucosidase suggests a diagnosis of <strong>Gaucher's disease</strong> that is inherited in an <strong>autosomal recessive</strong> pattern.</p>\n<p>Gaucher's disease:</p>\n<ul>\n<li>It is an inborn error of metabolism&nbsp;due to the <strong>deficiency</strong> of the enzyme&nbsp;<strong>glucocerebrosidase (&beta;-glucosidase)</strong>&nbsp;that leads to the accumulation of glucocerebroside in the lysosomes of cells.</li>\n<li>It is the&nbsp;<strong>most common lysosomal storage disorder.&nbsp;</strong></li>\n<li>The clinical features result from the accumulation of lipid-laden macrophages in the spleen, liver, bone marrow, bone, and other tissues.</li>\n<li>There are 3 clinical subtypes, delineated by the absence or presence and progression of neurologic manifestations:&nbsp;<strong>type 1, or the adult, nonneuronopathic</strong>&nbsp;form;<strong>&nbsp;type 2, the infantile or acute neuronopathic form</strong>; and type 3, the juvenile or subacute neuronopathic form</li>\n<li>Typical clinical features include&nbsp;<strong>delayed puberty</strong>, painless hepatomegaly and&nbsp;<strong>splenomegaly</strong>, liver cirrhosis, hypersplenism and pancytopenia,<strong> bleeding tendencies, bone pain</strong> due to&nbsp;<strong>avascular necrosis</strong>, osteoporosis, pathological fractures.</li>\n<li>Neurological symptoms such as developmental delay, hypertonia, strabismus, supranuclear gaze palsy (seen in type 3).</li>\n<li>Bone marrow examination usually reveals the presence of&nbsp;<strong>Gaucher cells</strong>&nbsp;(have a characteristic&nbsp;<strong>wrinkled-paper appearance</strong>)</li>\n<li>Enzyme replacement therapy for Gaucher's disease:<strong>&nbsp;<em>imiglucerase</em>,&nbsp;<em>velaglucerase alfa,&nbsp;</em><em>taliglucerase alfa,</em><em>eliglusta</em>t&nbsp;</strong></li>\n</ul><hr><h3>Related Pearl: Examples of Sphingolipidoses (Lipids-Storage Disease)</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eaf86bca861342ff84c303230efbb8bax1280x2017.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>S. No.</strong></p>\n</td>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Enzyme Deficiency</strong></p>\n</td>\n<td>\n<p><strong>Lipid </strong></p>\n<p><strong>Accumulating</strong></p>\n</td>\n<td>\n<p><strong>Clinical Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>Tay–Sachs disease</p>\n</td>\n<td>\n<p>Hexosaminidase A</p>\n</td>\n<td>\n<p>Ganglioside</p>\n</td>\n<td>\n<p>Mental retardation, blindness, muscular weakness</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2</p>\n</td>\n<td>\n<p>Sandhoff's disease</p>\n</td>\n<td>\n<p>Hexosaminidase A and B</p>\n</td>\n<td>\n<p>Globoside &amp; Ganglioside</p>\n</td>\n<td>\n<p>Similar to Tay–Sachs disease but also has hepatosplenomegaly and skeletal dysplasias</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3</p>\n</td>\n<td>\n<p>Fabry's disease</p>\n</td>\n<td>\n<p>α-Galactosidase</p>\n</td>\n<td>\n<p>Globotriaosyl-ceramide</p>\n</td>\n<td>\n<p>Skin rash, kidney failure (full symptoms only in males; X-linked recessive)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>4</p>\n</td>\n<td>\n<p>Metachromatic leukodystrophy</p>\n</td>\n<td>\n<p>Arylsulfatase A</p>\n</td>\n<td>\n<p>3-Sulfogalactosyl-ceramide</p>\n</td>\n<td>\n<p>Mental retardation and psychologic disturbances in adults; demyelination</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>5</p>\n</td>\n<td>\n<p>Krabbe disease</p>\n</td>\n<td>\n<p>β-Galactosidase</p>\n</td>\n<td>\n<p>Galactosylceramide</p>\n</td>\n<td>\n<p>Mental retardation; myelin almost absent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>6</p>\n</td>\n<td>\n<p>Gaucher's disease</p>\n</td>\n<td>\n<p>β-Glucosidase</p>\n</td>\n<td>\n<p>Glucosylceramide</p>\n</td>\n<td>\n<p>Enlarged liver and spleen, erosion of long bones, mental retardation in infants</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>7</p>\n</td>\n<td>\n<p>Niemann–Pick disease</p>\n</td>\n<td>\n<p>Sphingomyelinase</p>\n</td>\n<td>\n<p>Sphingomyelin</p>\n</td>\n<td>\n<p>Enlarged liver and spleen, mental retardation; fatal in early life</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>8</p>\n</td>\n<td>\n<p>Farber's disease</p>\n</td>\n<td>\n<p>Ceramidase</p>\n</td>\n<td>\n<p>Ceramide</p>\n</td>\n<td>\n<p>Hoarseness, dermatitis, skeletal deformation, mental retardation; fatal in early life</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9355",
      "difficulty": "medium"
    },
    {
      "text": "A 6-month-old infant with progressive failure to thrive and milestone regression is being evaluated for an inborn error of metabolism. On examination, hypotonia, apathy, deafness, hepatosplenomegaly, and generalized lymphadenopathy are present. Fundus examination is shown below. A liver biopsy shows foamy hepatocytes loaded with sphingomyelin. Electron microscopy reveals zebra bodies. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Niemann-Pick disease type A"
        },
        {
          "id": 2,
          "text": "Tay-Sach disease"
        },
        {
          "id": 3,
          "text": "Niemann-Pick disease type B"
        },
        {
          "id": 4,
          "text": "Sandhoff's disease"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical vignette along with the <strong>cherry-red spot</strong> on fundus examination suggests a diagnosis of<strong> Niemann-Pick disease type A- </strong>Lysosomal storage disorder due to an inherited <strong>deficiency of sphingomyelinase</strong></p>\n<p><strong>Type A</strong> is a severe<strong> infantile</strong> form with <strong>extensive neurologic involvement&nbsp;</strong>(hypotonia, milestone regression, apathy),<strong> marked visceral accumulations of sphingomyelin</strong> (hepatosplenomegaly, foamy hepatocytes, <strong>zebra bodies</strong> on EM), and<strong> progressive wasting and early death</strong> within the first 3 years of life.</p>\n<p>In contrast, patients with<strong> Niemann-Pick disease&nbsp;type B</strong> have organomegaly but generally <strong>no CNS involvement.</strong></p><hr><h3>Related Pearl: Examples of Sphingolipidoses (Lipids-Storage Disease)</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eaf86bca861342ff84c303230efbb8bax1280x2017.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>S. No.</strong></p>\n</td>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Enzyme Deficiency</strong></p>\n</td>\n<td>\n<p><strong>Lipid </strong></p>\n<p><strong>Accumulating</strong></p>\n</td>\n<td>\n<p><strong>Clinical Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>Tay–Sachs disease</p>\n</td>\n<td>\n<p>Hexosaminidase A</p>\n</td>\n<td>\n<p>Ganglioside</p>\n</td>\n<td>\n<p>Mental retardation, blindness, muscular weakness</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2</p>\n</td>\n<td>\n<p>Sandhoff's disease</p>\n</td>\n<td>\n<p>Hexosaminidase A and B</p>\n</td>\n<td>\n<p>Globoside &amp; Ganglioside</p>\n</td>\n<td>\n<p>Similar to Tay–Sachs disease but also has hepatosplenomegaly and skeletal dysplasias</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3</p>\n</td>\n<td>\n<p>Fabry's disease</p>\n</td>\n<td>\n<p>α-Galactosidase</p>\n</td>\n<td>\n<p>Globotriaosyl-ceramide</p>\n</td>\n<td>\n<p>Skin rash, kidney failure (full symptoms only in males; X-linked recessive)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>4</p>\n</td>\n<td>\n<p>Metachromatic leukodystrophy</p>\n</td>\n<td>\n<p>Arylsulfatase A</p>\n</td>\n<td>\n<p>3-Sulfogalactosyl-ceramide</p>\n</td>\n<td>\n<p>Mental retardation and psychologic disturbances in adults; demyelination</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>5</p>\n</td>\n<td>\n<p>Krabbe disease</p>\n</td>\n<td>\n<p>β-Galactosidase</p>\n</td>\n<td>\n<p>Galactosylceramide</p>\n</td>\n<td>\n<p>Mental retardation; myelin almost absent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>6</p>\n</td>\n<td>\n<p>Gaucher's disease</p>\n</td>\n<td>\n<p>β-Glucosidase</p>\n</td>\n<td>\n<p>Glucosylceramide</p>\n</td>\n<td>\n<p>Enlarged liver and spleen, erosion of long bones, mental retardation in infants</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>7</p>\n</td>\n<td>\n<p>Niemann–Pick disease</p>\n</td>\n<td>\n<p>Sphingomyelinase</p>\n</td>\n<td>\n<p>Sphingomyelin</p>\n</td>\n<td>\n<p>Enlarged liver and spleen, mental retardation; fatal in early life</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>8</p>\n</td>\n<td>\n<p>Farber's disease</p>\n</td>\n<td>\n<p>Ceramidase</p>\n</td>\n<td>\n<p>Ceramide</p>\n</td>\n<td>\n<p>Hoarseness, dermatitis, skeletal deformation, mental retardation; fatal in early life</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/58da6f5d165841efaef15a5c18363278.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9466",
      "difficulty": "medium"
    },
    {
      "text": "A male child with coarse facies, macroglossia, thick lips with hepatosplenomegaly presents with copious mucous discharge from the nose. The most probable underlying diagnosis is ________",
      "choices": [
        {
          "id": 1,
          "text": "Hurler disease"
        },
        {
          "id": 2,
          "text": "Beckwith-Wiedemann syndrome"
        },
        {
          "id": 3,
          "text": "Proteus Syndrome"
        },
        {
          "id": 4,
          "text": "Hypothyroidism"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario of a child with <strong>coarse facies</strong>, <strong>macroglossia</strong>, <strong>thick lips</strong>, <strong>hepatosplenomegaly</strong>, and copious <strong>discharge from the nose</strong> is suggestive of<strong> Hurler's disease</strong>.</p>\n<p>It is the severe form of <strong>mucopolysaccharidoses type 1</strong> (MPS 1), an<strong> autosomal recessive</strong> disorder caused by a defect in <strong>&alpha;-L iduronidase</strong>, leading to the accumulation of <strong>heparan sulfate</strong> and <strong>dermatan sulfate</strong>. The child usually presents between <strong>6 and 24 months</strong> with hepatosplenomegaly, coarse facial features (shown below), <strong>corneal clouding</strong>, <strong>large tongue</strong>, prominent forehead, joint stiffness, <strong>short</strong> <strong>stature</strong>, and <strong>skeletal dysplasia</strong>.</p>\n<p>Most patients have recurrent upper respiratory tract and ear infections, <strong>noisy breathing</strong>, and persistent copious nasal discharge. Radiograph shows skeletal dysplasia, called <strong>dysostosis multiplex</strong> - <strong>thick ribs</strong>, <strong>ovoid vertebral bodies</strong>, enlarged and <strong>trabeculated diaphyses</strong> of the long bones with <strong>irregular</strong> <strong>metaphysis</strong> and <strong>epiphysis</strong>.</p>\n<p>Macrocephaly, enlarged J-shaped sella, premature closure of lambdoid sagittal sutures, and shallow orbits are seen with disease progression.&nbsp;Obstructive airway disease, cardiac complications, and respiratory infections are the common causes of death.&nbsp;</p>\n<p>The image below shows the radiograph shows <strong>enlarged diaphyses</strong> of the metacarpal and phalanges.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bc2784866d7a414fad4a7a7c99f36f1dx720x1757.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option B: <strong>Beckwith-Wiedemann</strong> syndrome is an overgrowth syndrome characterized by <strong>macrosomia</strong>, <strong>macroglossia</strong>,<strong> hemihypertrophy</strong>, <strong>omphalocele</strong>, and renal anomalies. It is associated with an increased risk of <strong>Wilms tumor</strong>, hepatoblastoma, rhabdomyosarcoma, neuroblastoma, and adrenal cortical carcinoma.</p>\n<p>Option C: <strong>Proteus syndrome</strong> is a disturbance of cellular growth involving ectodermal and mesodermal tissues, caused by mutation in the AKT1 gene. They present with <strong>hemimegalencephaly</strong>, asymmetric <strong>overgrowth of the extremities</strong>, verrucous cutaneous lesions, thickening of the bone, and excessive growth of muscles.</p>\n<p>Option D: A child with untreated <strong>congenital hypothyroidism</strong> may have stunted growth, short extremities, narrow palpebral fissures, swollen eyelids, depressed nasal bridge, thick broad protruded tongue, and short and thick neck, dry and scaly skin.&nbsp;</p><hr><h3>Related Pearl: MPS and Their Respective Enzyme Deficiencies</h3><table>\n<tbody>\n<tr>\n<td><strong>Disease</strong></td>\n<td><strong>MPS</strong></td>\n<td><strong>Enzyme defective</strong></td>\n<td><strong>GAGs affected</strong></td>\n<td><strong>Symptoms</strong></td>\n</tr>\n<tr>\n<td>Hurler-, Scheie-,&nbsp;<br />Hurler-scheie syndrome</td>\n<td>MPS I</td>\n<td>&alpha;-L-Iduronidase</td>\n<td>\n<p>Dermatan sulfate,<br />Heparan sulfate</p>\n</td>\n<td>Mental retardation,<br />coarse facial features,&nbsp;<br />Hepatosplenomegaly<br />Cloudy cornea</td>\n</tr>\n<tr>\n<td>Hunter syndrome</td>\n<td>MPS II</td>\n<td>Iduronate sulfatase</td>\n<td>Dermatan sulfate,&nbsp;<br />Heparan sulfate</td>\n<td>Mental retardation</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome A</td>\n<td>MPS IIIA</td>\n<td>Heparan sulfate-N-sulfatase</td>\n<td>Heparan sulfate</td>\n<td>Delay in development<br />Motor dysfunction</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome B</td>\n<td>MPS III B</td>\n<td>&alpha;-N-Acetylglucosaminidase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome C</td>\n<td>MPS III C</td>\n<td>&alpha;-glucosaminide N-acetyltransferase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A &nbsp;</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome D</td>\n<td>MPS III D</td>\n<td>N-acetylglucosamine 6-sulfatase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A &nbsp;</td>\n</tr>\n<tr>\n<td>Morquio syndrome A</td>\n<td>MPS IV A</td>\n<td>Galactosamine&nbsp;6-sulfatase</td>\n<td>Keratan sulfate&nbsp;<br />Chondroitin 6-sulfate&nbsp;</td>\n<td>Skeletal dysplasia<br />short stature</td>\n</tr>\n<tr>\n<td>Morquio syndrome B</td>\n<td>MPS IV B</td>\n<td>&beta;-galactosidase</td>\n<td>Keratan sulfate</td>\n<td>As MPS IV A</td>\n</tr>\n<tr>\n<td>Maroteaux-lamy&nbsp;syndrome&nbsp;</td>\n<td>MPS VI</td>\n<td>N-acetylgalactosamine 4-sulfatase</td>\n<td>Dermatan sulfate</td>\n<td>Curvature of the spine,<br />Short stature<br />Skeletal dysplasia<br />Cardiac defects</td>\n</tr>\n<tr>\n<td>Sly&nbsp;syndrome&nbsp;</td>\n<td>MPS VII</td>\n<td>&beta;-glucuronidase</td>\n<td>Dermatan sulfate<br />Heparan sulfate<br />Chondroitin 4-sulfate&nbsp;<br />Chondroitin 6-sulfate&nbsp;<br /><br /></td>\n<td>Short stature<br />Skeletal dysplasia<br />Hepatomegaly<br />Cloudy cornea</td>\n</tr>\n<tr>\n<td>Natowicz&nbsp;syndrome&nbsp;</td>\n<td>MPS IX</td>\n<td>Hyaluronidase</td>\n<td>Hyaluronic acid</td>\n<td>Joint Pain<br />Short stature&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3213",
      "difficulty": "medium"
    },
    {
      "text": "A case series reviews children with lysosomal storage disorders who usually present with dysmorphic facies, organomegaly, milestones regression, and failure to thrive. Which of the following disorders does not have enzyme replacement therapy as a therapeutic option?",
      "choices": [
        {
          "id": 1,
          "text": "Gaucher's disease"
        },
        {
          "id": 2,
          "text": "Pompe disease"
        },
        {
          "id": 3,
          "text": "Sanfilippo syndrome"
        },
        {
          "id": 4,
          "text": "Fabry's disease"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Enzyme replacement therapy is not available for&nbsp;Sanfilippo syndrome (MPS type III).</p><hr><h3>Related Pearl: Enzyme Replacement Therapy for Lysosomal Storage Disorders</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;Lysosomal Storage Disorder</strong></p>\n</td>\n<td>\n<p><strong>Enzyme deficient</strong></p>\n</td>\n<td>\n<p><strong>Enzyme Replacement Therapy</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hurler Syndrome (MPS I)</p>\n</td>\n<td>\n<p>&alpha;-L -iduronidase</p>\n</td>\n<td>\n<p>Laronidase (Aldurazyme)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hunter Syndrome (MPS II)</p>\n</td>\n<td>\n<p>Iduronate sulfate sulfatase</p>\n</td>\n<td>\n<p>Idursulfase (Elaprase)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Morquio A Syndrome (MPS IVA)</p>\n</td>\n<td>\n<p>N-Acetylgalactosamine-6-sulfate sulfatase</p>\n</td>\n<td>\n<p>Elosulfase (Vimizim)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maroteaux&ndash;Lamy Syndrome (MPS VI)</p>\n</td>\n<td>\n<p>N -Acetylgalactosamine-&alpha;-4-sulfate sulfatase (arylsulfatase B)</p>\n</td>\n<td>\n<p>Galsulfase (Naglazyme)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sly syndrome (MPS VII)</p>\n</td>\n<td>&beta;-Glucuronidase</td>\n<td>\n<p>rhGUS (recombinant human&nbsp;&beta;-Glucuronidase is under Phase III trial)</p>\n</td>\n</tr>\n<tr>\n<td>Wolman disease</td>\n<td>Lysosomal acid lipase</td>\n<td>\n<p><em> Sebelipase alfa</em>(Kanuma, Alexion)</p>\n</td>\n</tr>\n<tr>\n<td>Metachromatic leukodystrophy</td>\n<td>Arylsulfatase A</td>\n<td>\n<p>rhARSA (recombinant human arylsulfatase A is under Phase I/II trial)</p>\n</td>\n</tr>\n<tr>\n<td>Fabry disease&nbsp;</td>\n<td>&alpha;-galactosidase A</td>\n<td>\n<p><em>agalsidase beta</em> (Fabrazyme, Genzyme)</p>\n<p><em>agalsidase alfa</em> (Replagal, Shire HGT)</p>\n</td>\n</tr>\n<tr>\n<td>Gaucher disease</td>\n<td>&beta;-glucosidase</td>\n<td>\n<p><em>imiglucerase </em>[Cerezyme, Genzyme]</p>\n<p><em>velaglucerase alfa </em>[VPRIV, Shire HGT]</p>\n<p><em>taliglucerase alfa </em>(Uplyso, Protalix<br />Biotherapeutics)</p>\n<p><em>eliglusta</em>t (Cerdelga, Sanofi-Genzyme)</p>\n</td>\n</tr>\n<tr>\n<td>Pompe disease</td>\n<td>acid &alpha;-1,4-glucosidase (acid maltase)&nbsp;</td>\n<td>\n<p><em>alglucosidase alfa </em>(Myozyme)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3408",
      "difficulty": "medium"
    },
    {
      "text": "A 3-month-old female child was brought to the clinic with a history of failure to thrive. On examination,  generalized hypotonia and hepatomegaly were present. A chest X-ray image shows massive cardiomegaly. A muscle biopsy is performed and the findings are attached in the image below. Which of the following is the most likely enzyme that is involved in the suspected condition?",
      "choices": [
        {
          "id": 1,
          "text": "Glucose-6-phosphatase"
        },
        {
          "id": 2,
          "text": "Lysosomal acid alpha-glucosidase"
        },
        {
          "id": 3,
          "text": "Muscle glycogen phosphorylase"
        },
        {
          "id": 4,
          "text": "Glycogen debranching enzyme"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The muscle biopsy shows the presence of <strong>large vacuoles</strong>. This along with the clinical vignette is strongly suggestive of <strong>Pompe's disease</strong> or type II glycogen storage disease.&nbsp;It&nbsp;is caused due to the deficiency of the enzyme<strong>&nbsp;lysosomal acid alpha-glucosidase.</strong></p>\n<p>Clinically, the child presents with <strong>hypotonia,</strong><strong>&nbsp;hepatomegaly, hypertrophic cardiomyopathy.</strong>&nbsp;The affected child usually dies around the age of 2 years due to heart failure.</p>\n<p>Investigations include&nbsp;chest X-ray imaging which shows<strong> cardiomegaly.&nbsp;</strong>The muscle biopsy showing vacuoles further aids the diagnosis.&nbsp;</p>\n<p>Treatment includes&nbsp;enzyme replacement therapy with recombinant enzyme <strong>a-glucosidase alfa</strong> (Myozyme).</p><hr><h3>Related Pearl: Glycogen Storage Diseases</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/782e85c36f0648698a222dca988adfabx1280x1863.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Enzyme deficiency</strong></p>\n</td>\n<td>\n<p><strong>Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type 0</p>\n</td>\n<td>\n<p>Glycogen synthase</p>\n</td>\n<td>\n<p>Hypoglycemia</p>\n<p>Early death</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type Ia</p>\n<p><strong>Von Gierke's disease</strong></p>\n</td>\n<td>\n<p>Glucose-6- phosphatase</p>\n</td>\n<td>\n<p>Hepatomegaly and renomegaly&nbsp;due to glycogen accumulation</p>\n<p>Severe fasting hypoglycemia</p>\n<p>Growth failure</p>\n<p>Lactic acidosis</p>\n<p>Hyperuricemia</p>\n<p>Hyperlipidemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type Ib</p>\n</td>\n<td>\n<p>Endoplasmic reticulum glucose-6- phosphate transporter</p>\n</td>\n<td>\n<p>Same as Von Gierke's disease</p>\n<p>Recurrent infections due to impaired neutrophil function</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type II</p>\n<p><strong>Pompe's disease</strong></p>\n</td>\n<td>\n<p>Lysosomal &alpha;1,4:1,6 glucosidase</p>\n<p>(Acid maltase)</p>\n</td>\n<td>\n<p>Muscle weakness</p>\n<p>Death by age ~ 2 years (infantile variant)</p>\n<p>Cardiomegaly and heart failure</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type III</p>\n<p><strong>Cori's/Forbes disease</strong></p>\n<p>(Limit dextrinosis)</p>\n</td>\n<td>\n<p>Glycogen debranching enzyme</p>\n</td>\n<td>\n<p>Muscle weakness</p>\n<p>Fasting hypoglycemia</p>\n<p>Hepatomegaly due to accumulation of branched-chain polysaccharide (limit dextrins)</p>\n<p>Growth retardation</p>\n<p>Normal lactate and uric acid levels</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type IV</p>\n<p><strong>Andersen disease</strong></p>\n</td>\n<td>\n<p>Glycogen branching enzyme</p>\n</td>\n<td>\n<p>Failure to thrive</p>\n<p>Hepatomegaly due to accumulation of polysaccharides with few branch points</p>\n<p>Death at age ~ 5 years</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type V</p>\n<p><strong>McArdle disease</strong></p>\n</td>\n<td>\n<p>Muscle glycogen phosphorylase</p>\n</td>\n<td>\n<p>Exercise-induced cramps</p>\n<p>Renal failure due to rhabdomyolysis and myoglobinuria</p>\n<p>Second wind phenomenon</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type VI</p>\n<p><strong>Her's disease</strong></p>\n</td>\n<td>\n<p>Liver glycogen phosphorylase</p>\n</td>\n<td>\n<p>Generally benign</p>\n<p>Mild hypoglycemia</p>\n<p>Hepatomegaly</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type VII</p>\n<p><strong>Tarui's disease</strong></p>\n</td>\n<td>\n<p>Muscle phosphofructokinase</p>\n</td>\n<td>\n<p>Exercise-induced muscle cramps and weakness</p>\n<p>Growth retardation</p>\n<p>Hemolytic anemia</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/37985bd17c3148b5892954d3940663fe.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9350",
      "difficulty": "medium"
    },
    {
      "text": "A 6-month-old is brought by his parents with a history of decreased weight gain. On examination, you find that the baby has hepatosplenomegaly, muscle weakness and atrophy, hypotonia, and decreased deep tendon reflexes. Blood tests reveal normal glucose levels. Biopsy of the liver reveals initial stages of cirrhosis due to the accumulation of abnormal glycogen with few branch points, whose structure resembles amylopectin. The clinical and laboratory results are indicative of which glycogen storage disease?",
      "choices": [
        {
          "id": 1,
          "text": "Von Gierke disease"
        },
        {
          "id": 2,
          "text": "Andersen disease"
        },
        {
          "id": 3,
          "text": "McArdle disease"
        },
        {
          "id": 4,
          "text": "Tarui disease"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical and laboratory features indicate <strong>Andersen's disease</strong> in the baby. Inability to gain weight, hepatosplenomegaly, muscle weakness, and accumulation of abnormal glycogen resembling amylopectin point towards the diagnosis.</p>\n<p><strong>Andersen's disease</strong> is type IV glycogen storage disease. It is transmitted in an <strong>autosomal recessive</strong> pattern and occurs due to a deficiency of&nbsp;<strong>glycogen branching enzyme </strong>because of pathologic variants in the GBE1 gene. This leads to accumulation of of an abnormal structure of glycogen known as <strong>polyglucosan</strong>.&nbsp; It is characterized by</p>\n<ul>\n<li>Growth delay</li>\n<li>Hepatomegaly due to the accumulation of polysaccharides with few branch points</li>\n<li>Myopathy</li>\n<li>There might be fasting intolerance and ketosis in the initial stages. Hypoglycemia usually appears late in the disease when it is associated with cirrhosis, esophageal varices, and ascites.<span class=\"Apple-converted-space\">&nbsp;</span></li>\n<li><strong>Biopsy of the liver</strong> will show the presence of abnormal glycogen which resembles <strong>amylopectin</strong>. Amylopectin is found in plants and has very few branches. Since there is a defect in the branching of the glycogen, the abnormal glycogen appears like amylopectin.</li>\n</ul>\n<p class=\"p2\">The diagnosis is confirmed by absent branching enzyme activity in skin fibroblasts, muscle, or liver and analysis of the DNA mutation.</p>\n<p><strong>Von Gierke's disease&nbsp;</strong>(Option A)&nbsp;has features of lactic acidosis, hypoglycemia, hyperuricemia, impaired growth, and bone thinning. It occurs due to a defect in the glucose 6-phosphatase.</p>\n<p><strong>McArdle disease</strong> (Option C) usually manifests as&nbsp;exercise intolerance, muscle cramping with exercise. It is usually a benign chronic condition. It occurs due to a defect in the muscle glycogen phosphorylase.</p>\n<p><strong>Tarui disease</strong> (Option D)&nbsp;also presents similar to the McArdle disease. Patients may have developmental delay, and hemolytic anemia in addition to exercise-induced muscle cramps.&nbsp;It occurs due to a defect in the <strong>muscle phosphofructokinase</strong>.</p><hr><h3>Related Pearl: Glycogen Storage Diseases</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/782e85c36f0648698a222dca988adfabx1280x1863.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Enzyme deficiency</strong></p>\n</td>\n<td>\n<p><strong>Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type 0</p>\n</td>\n<td>\n<p>Glycogen synthase</p>\n</td>\n<td>\n<p>Hypoglycemia</p>\n<p>Early death</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type Ia</p>\n<p><strong>Von Gierke's disease</strong></p>\n</td>\n<td>\n<p>Glucose-6- phosphatase</p>\n</td>\n<td>\n<p>Hepatomegaly and renomegaly&nbsp;due to glycogen accumulation</p>\n<p>Severe fasting hypoglycemia</p>\n<p>Growth failure</p>\n<p>Lactic acidosis</p>\n<p>Hyperuricemia</p>\n<p>Hyperlipidemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type Ib</p>\n</td>\n<td>\n<p>Endoplasmic reticulum glucose-6- phosphate transporter</p>\n</td>\n<td>\n<p>Same as Von Gierke's disease</p>\n<p>Recurrent infections due to impaired neutrophil function</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type II</p>\n<p><strong>Pompe's disease</strong></p>\n</td>\n<td>\n<p>Lysosomal &alpha;1,4:1,6 glucosidase</p>\n<p>(Acid maltase)</p>\n</td>\n<td>\n<p>Muscle weakness</p>\n<p>Death by age ~ 2 years (infantile variant)</p>\n<p>Cardiomegaly and heart failure</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type III</p>\n<p><strong>Cori's/Forbes disease</strong></p>\n<p>(Limit dextrinosis)</p>\n</td>\n<td>\n<p>Glycogen debranching enzyme</p>\n</td>\n<td>\n<p>Muscle weakness</p>\n<p>Fasting hypoglycemia</p>\n<p>Hepatomegaly due to accumulation of branched-chain polysaccharide (limit dextrins)</p>\n<p>Growth retardation</p>\n<p>Normal lactate and uric acid levels</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type IV</p>\n<p><strong>Andersen disease</strong></p>\n</td>\n<td>\n<p>Glycogen branching enzyme</p>\n</td>\n<td>\n<p>Failure to thrive</p>\n<p>Hepatomegaly due to accumulation of polysaccharides with few branch points</p>\n<p>Death at age ~ 5 years</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type V</p>\n<p><strong>McArdle disease</strong></p>\n</td>\n<td>\n<p>Muscle glycogen phosphorylase</p>\n</td>\n<td>\n<p>Exercise-induced cramps</p>\n<p>Renal failure due to rhabdomyolysis and myoglobinuria</p>\n<p>Second wind phenomenon</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type VI</p>\n<p><strong>Her's disease</strong></p>\n</td>\n<td>\n<p>Liver glycogen phosphorylase</p>\n</td>\n<td>\n<p>Generally benign</p>\n<p>Mild hypoglycemia</p>\n<p>Hepatomegaly</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type VII</p>\n<p><strong>Tarui's disease</strong></p>\n</td>\n<td>\n<p>Muscle phosphofructokinase</p>\n</td>\n<td>\n<p>Exercise-induced muscle cramps and weakness</p>\n<p>Growth retardation</p>\n<p>Hemolytic anemia</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9353",
      "difficulty": "medium"
    },
    {
      "text": "A 6-year-old boy develops hypoglycemia and muscle weakness with moderate activity. On examination, he had hepatomegaly and growth restriction. Investigations revealed the accumulation of limit dextrins and increased glycogen deposits in the liver. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Cori's disease"
        },
        {
          "id": 2,
          "text": "von Gierke's disease"
        },
        {
          "id": 3,
          "text": "Anderson's disease"
        },
        {
          "id": 4,
          "text": "Pompe's disease"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The most likely diagnosis is<strong> Cori disease.</strong></p>\n<p>Glycogen debrancher deficiency (Glycogen Storage Disease III) is also known as <strong>Cori disease</strong>, Forbes disease, and<strong> limit dextrinosis.</strong></p>\n<p>Cori&rsquo;s disease may be clinically indistinguishable from von Gierke&rsquo;s disease in infancy and childhood as hypoglycemia, hepatomegaly, hyperlipidemia, and growth retardation is common. Accumulation of limit dextrins is unique to Cori's disease. <strong>Definitive diagnosis</strong> is through <strong>enzyme assays</strong> in the liver, muscle, or both.</p><hr><h3>Related Pearl: Glycogen Storage Diseases</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/782e85c36f0648698a222dca988adfabx1280x1863.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Enzyme deficiency</strong></p>\n</td>\n<td>\n<p><strong>Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type 0</p>\n</td>\n<td>\n<p>Glycogen synthase</p>\n</td>\n<td>\n<p>Hypoglycemia</p>\n<p>Early death</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type Ia</p>\n<p><strong>Von Gierke's disease</strong></p>\n</td>\n<td>\n<p>Glucose-6- phosphatase</p>\n</td>\n<td>\n<p>Hepatomegaly and renomegaly&nbsp;due to glycogen accumulation</p>\n<p>Severe fasting hypoglycemia</p>\n<p>Growth failure</p>\n<p>Lactic acidosis</p>\n<p>Hyperuricemia</p>\n<p>Hyperlipidemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type Ib</p>\n</td>\n<td>\n<p>Endoplasmic reticulum glucose-6- phosphate transporter</p>\n</td>\n<td>\n<p>Same as Von Gierke's disease</p>\n<p>Recurrent infections due to impaired neutrophil function</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type II</p>\n<p><strong>Pompe's disease</strong></p>\n</td>\n<td>\n<p>Lysosomal &alpha;1,4:1,6 glucosidase</p>\n<p>(Acid maltase)</p>\n</td>\n<td>\n<p>Muscle weakness</p>\n<p>Death by age ~ 2 years (infantile variant)</p>\n<p>Cardiomegaly and heart failure</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type III</p>\n<p><strong>Cori's/Forbes disease</strong></p>\n<p>(Limit dextrinosis)</p>\n</td>\n<td>\n<p>Glycogen debranching enzyme</p>\n</td>\n<td>\n<p>Muscle weakness</p>\n<p>Fasting hypoglycemia</p>\n<p>Hepatomegaly due to accumulation of branched-chain polysaccharide (limit dextrins)</p>\n<p>Growth retardation</p>\n<p>Normal lactate and uric acid levels</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type IV</p>\n<p><strong>Andersen disease</strong></p>\n</td>\n<td>\n<p>Glycogen branching enzyme</p>\n</td>\n<td>\n<p>Failure to thrive</p>\n<p>Hepatomegaly due to accumulation of polysaccharides with few branch points</p>\n<p>Death at age ~ 5 years</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type V</p>\n<p><strong>McArdle disease</strong></p>\n</td>\n<td>\n<p>Muscle glycogen phosphorylase</p>\n</td>\n<td>\n<p>Exercise-induced cramps</p>\n<p>Renal failure due to rhabdomyolysis and myoglobinuria</p>\n<p>Second wind phenomenon</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type VI</p>\n<p><strong>Her's disease</strong></p>\n</td>\n<td>\n<p>Liver glycogen phosphorylase</p>\n</td>\n<td>\n<p>Generally benign</p>\n<p>Mild hypoglycemia</p>\n<p>Hepatomegaly</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type VII</p>\n<p><strong>Tarui's disease</strong></p>\n</td>\n<td>\n<p>Muscle phosphofructokinase</p>\n</td>\n<td>\n<p>Exercise-induced muscle cramps and weakness</p>\n<p>Growth retardation</p>\n<p>Hemolytic anemia</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3215",
      "difficulty": "medium"
    },
    {
      "text": "A 5-day-old neonate is brought to the emergency room with vomiting and poor feeding. Breastfeeding was initiated soon after birth. On examination, the child is lethargic and has hepatomegaly. Labs reveal increased plasma galactose and increased urine galactitol levels. Examination of the mother shows the presence of skin lesions on the breast with the histopathological appearance showing characteristic 'Cowdry Type A' inclusions as shown below. Choose the correct statements from those below:<div class='question-desc-html'><ol>\n<li>The child's condition is an absolute contraindication to breastfeeding</li>\n<li>The mother's condition is an&nbsp;absolute contraindication to breastfeeding</li>\n<li>The child is prone to E.coli sepsis</li>\n<li>The child is prone to sepsis caused by S. aureus</li>\n<li>The mother has a risk of recurrence of her condition</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "2 and 4 are correct"
        },
        {
          "id": 2,
          "text": "1, 3, and 5 are correct"
        },
        {
          "id": 3,
          "text": "2 and 5 are correct"
        },
        {
          "id": 4,
          "text": "1,3, and 4 are correct"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical complex describes a case of <strong>classic galactosemia in the infant</strong> (increased plasma galactose and urine galactitol levels) and <strong>herpes simplex of the breast in the mother</strong> (histopathology shown in the image has large multinucleate virus-infected cells with typical&nbsp;eosinophilic Cowdry Type A inclusions).</p>\n<p><strong>Galactosemia</strong> is an<strong> absolute contraindication</strong> to breastfeeding and the child is at risk for E.coli sepsis. <strong>Herpes lesions on the breast</strong> are a<strong> relative contraindication</strong> to <strong>breastfeeding</strong> and she is at risk for recurrence.&nbsp;</p>\n<p><strong>&nbsp;Deficiency</strong> of <strong>galactose-1-uridyltransferase</strong> leads to the accumulation of galactose-1-phosphate and galactitol causes <strong>classic galactosemia.</strong></p>\n<p>Infants show vomiting, diarrhea, and poor weight gain <strong>within 3-4 days of breastfeeding.</strong><strong>Jaundice</strong> and liver dysfunction appear in the first or second week of life.&nbsp;Untreated children may show nuclear cataracts (<strong>oil-droplet cataract</strong>), vitreous hemorrhage, hepatic failure, cirrhosis, ascites, splenomegaly, or intellectual disability.&nbsp;<strong>The proximal renal tubular disease</strong> may also manifest as metabolic acidosis, galactosuria, glucosuria, and aminoaciduria. The most common cause of death is <strong>E.coli sepsis.</strong>Acute galactose toxicity is manifested by neurological symptoms</p>\n<p>Diagnosis is made by genetic or mutational analysis. There will the presence of reducing substances in the urine.&nbsp;<strong>Elimination of galactose</strong> from the diet along with adequate calcium supplementation <strong>reverses growth failure and renal and hepatic dysfunction.</strong></p>\n<p>&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/0937ef61b0a44a9a9a9c6dd3bdcdcd28.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9351",
      "difficulty": "medium"
    },
    {
      "text": "A father has noticed that whenever his daughter drinks fruit juice she has multiple episodes of vomiting. He reports to you that his daughter is allergic to fruit juice. Which of the following enzyme deficiency is likely?",
      "choices": [
        {
          "id": 1,
          "text": "Aldolase B"
        },
        {
          "id": 2,
          "text": "Fructokinase"
        },
        {
          "id": 3,
          "text": "Glucose 6-phosphatase"
        },
        {
          "id": 4,
          "text": "Hexokinase"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Aldolase B</strong> deficiency is likely in this child.</p>\n<p>In the given case scenario, the child becomes symptomatic after ingesting fruit juice that contains fructose; this indicates that she has <strong>hereditary fructose intolerance, which is caused by the deficiency of aldolase B.</strong></p>\n<p><strong>Deficiency of fructose-1,6- bisphosphate aldolase (Aldolase B hereditary fructose intolerance):&nbsp;</strong><strong>Fructose aldolase B </strong>is&nbsp;present in the liver, kidney, and intestine. It catalyzes the hydrolysis of fructose-1,6-bisphosphate into triose phosphate and glyceraldehyde phosphate.</p>\n<p>Clinical features: Patients are asymptomatic until fructose or sucrose&nbsp;is ingested (usually from fruit, fruit juice, sweetened cereal, or table sugar). Clinical features include&nbsp;jaundice, hepatomegaly, vomiting, lethargy, irritability,&nbsp;and convulsions. It resembles galactosemia. Acute ingestion causes symptomatic hypoglycemia. Chronic intake results in failure to thrive and hepatic disease. The persistence of fructose intake can lead to liver failure, kidney failure,&nbsp;and death.</p>\n<p>Diagnosis:<strong> Reducing substance</strong> is seen in the <strong>urine</strong> during an episode (<strong>Benedict's test +</strong>). An assay&nbsp;of <strong>fructaldolase B activity in the liver</strong> gives a <strong>definitive diagnosis.</strong></p>\n<p>Treatment: Complete elimination of all sources of sucrose, fructose, and sorbitol from the diet. With age, symptoms become milder even after fructose ingestion. The long-term prognosis is good.</p>\n<p><strong>Note:</strong></p>\n<p><strong>The deficiency of fructokinase</strong> is not associated with any clinical manifestations. Fructosuria is an<strong> accidental finding</strong> usually made because the<strong> asymptomatic</strong> patient's urine contains a reducing substance. No treatment is necessary, and the<strong> prognosis is excellent.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3407",
      "difficulty": "medium"
    },
    {
      "text": "\"Tomcat urine\"  is characteristically seen in ________",
      "choices": [
        {
          "id": 1,
          "text": "Tyrosinemia"
        },
        {
          "id": 2,
          "text": "Multiple carboxylase deficiency"
        },
        {
          "id": 3,
          "text": "Phenylketonuria"
        },
        {
          "id": 4,
          "text": "Trimethylaminuria"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Tomcat urine</strong> is characteristically seen in<strong> multiple carboxylase deficiency</strong>.</p>\n<p>It is named so because of its <strong>peculiar odour.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7659",
      "difficulty": "easy"
    },
    {
      "text": "The enzyme deficient in hereditary coproporphyria is ________",
      "choices": [
        {
          "id": 1,
          "text": "Coproporphyrinogen oxidase (CPOX)"
        },
        {
          "id": 2,
          "text": "Protoporphyrinogen oxidase (PPOX)"
        },
        {
          "id": 3,
          "text": "Porphobilinogen deaminase (PBGD)"
        },
        {
          "id": 4,
          "text": "Ferrochelatase (FECH)"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The enzyme deficient in hereditary coproporphyria is coproporphyrinogen oxidase (CPOX).</p>\n<p><strong>Hereditary coproporphyria (HCP):</strong></p>\n<ul>\n<li>Autosomal-dominant hepatic porphyria is caused by the<strong>&nbsp;deficiency of CPOX. </strong></li>\n<li>Acute attacks of HCP are treated as in acute intermittent porphyria (AIP), which includes intravenous hemin and identifying and avoiding precipitating factors. Cholestyramine may be of some value for photosensitivity occurring with liver dysfunction.</li>\n<li>Gonadotropin-releasing hormone analogs can be effective for the prevention of cyclic attacks.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7669",
      "difficulty": "medium"
    },
    {
      "text": "Deficiency of the enzyme porphobilinogen deaminase causes _____________",
      "choices": [
        {
          "id": 1,
          "text": "Porphyria cutanea tarda"
        },
        {
          "id": 2,
          "text": "Acute intermittent porphyria"
        },
        {
          "id": 3,
          "text": "Variegate porphyria"
        },
        {
          "id": 4,
          "text": "X-Linked protoporphyria"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Deficiency of the enzyme <strong>porphobilinogen deaminase</strong> causes <strong>acute intermittent porphyria</strong>.</p>\n<p>Other options:</p>\n<ul>\n<li>Porphyria cutanea tarda: Deficiency of Uroporphyrinogen decarboxylase (UROD)</li>\n<li>Variegate porphyria: Deficiency of Protoporphyrinogen oxidase (PPOX)</li>\n<li>&nbsp;X-Linked protoporphyria: Gain of function mutation of &delta;-aminolevulinate synthase 2 (ALAS2)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7666",
      "difficulty": "medium"
    },
    {
      "text": "A mother who is a hairstylist has noted that her baby's hair looks dull, breaks off easily, and is tufted. She brings the child to you and informs you about the past history of seizures. Investigations reveal elevated plasma ammonia levels and argininosuccinate levels. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Argininemia"
        },
        {
          "id": 2,
          "text": "Argininosuccinic aciduria"
        },
        {
          "id": 3,
          "text": "Hyperammonemia type 1"
        },
        {
          "id": 4,
          "text": "Hyperammonemia type 2"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The most likely diagnosis is <strong>argininosuccinic aciduria</strong> due to <strong>argininosuccinate lyase</strong> deficiency.</p>\n<p>It is accompanied by high levels of argininosuccinate levels in blood, CSF, and urine. It is also associated with friable, tufted hair known as <strong>trichorrhexis nodosa.</strong></p>\n<p>Image showing Trichorrhexis nodosa:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/dc7d409a3d8b4a09bbd932eed8f68b73x444x483.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Urea Cycle and its disorders</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/18bcc23295f14f9f9b7463912fdb6eeax1280x2235.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7272",
      "difficulty": "medium"
    },
    {
      "text": "Accumulation of ______ takes place in Farber’s disease.",
      "choices": [
        {
          "id": 1,
          "text": "Lecithin"
        },
        {
          "id": 2,
          "text": "Ceramide"
        },
        {
          "id": 3,
          "text": "Sphingomyelin"
        },
        {
          "id": 4,
          "text": "Sulfatides"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Accumulation of Ceramide</strong> is seen in <strong>Farber&rsquo;s disease </strong>due to<strong>&nbsp;ceramidase deficiency.</strong></p>\n<p><strong>&nbsp;</strong>Clinical features of Farber&rsquo;s disease :</p>\n<ul>\n<li>Painful joint swelling, nodules, progressive joint deformity</li>\n<li>Hoarse cry</li>\n<li>Breathing difficulty</li>\n<li>Failure to thrive</li>\n</ul><hr><h3>Related Pearl: Examples of Sphingolipidoses (Lipids-Storage Disease)</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eaf86bca861342ff84c303230efbb8bax1280x2017.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>S. No.</strong></p>\n</td>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Enzyme Deficiency</strong></p>\n</td>\n<td>\n<p><strong>Lipid </strong></p>\n<p><strong>Accumulating</strong></p>\n</td>\n<td>\n<p><strong>Clinical Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>Tay–Sachs disease</p>\n</td>\n<td>\n<p>Hexosaminidase A</p>\n</td>\n<td>\n<p>Ganglioside</p>\n</td>\n<td>\n<p>Mental retardation, blindness, muscular weakness</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2</p>\n</td>\n<td>\n<p>Sandhoff's disease</p>\n</td>\n<td>\n<p>Hexosaminidase A and B</p>\n</td>\n<td>\n<p>Globoside &amp; Ganglioside</p>\n</td>\n<td>\n<p>Similar to Tay–Sachs disease but also has hepatosplenomegaly and skeletal dysplasias</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3</p>\n</td>\n<td>\n<p>Fabry's disease</p>\n</td>\n<td>\n<p>α-Galactosidase</p>\n</td>\n<td>\n<p>Globotriaosyl-ceramide</p>\n</td>\n<td>\n<p>Skin rash, kidney failure (full symptoms only in males; X-linked recessive)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>4</p>\n</td>\n<td>\n<p>Metachromatic leukodystrophy</p>\n</td>\n<td>\n<p>Arylsulfatase A</p>\n</td>\n<td>\n<p>3-Sulfogalactosyl-ceramide</p>\n</td>\n<td>\n<p>Mental retardation and psychologic disturbances in adults; demyelination</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>5</p>\n</td>\n<td>\n<p>Krabbe disease</p>\n</td>\n<td>\n<p>β-Galactosidase</p>\n</td>\n<td>\n<p>Galactosylceramide</p>\n</td>\n<td>\n<p>Mental retardation; myelin almost absent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>6</p>\n</td>\n<td>\n<p>Gaucher's disease</p>\n</td>\n<td>\n<p>β-Glucosidase</p>\n</td>\n<td>\n<p>Glucosylceramide</p>\n</td>\n<td>\n<p>Enlarged liver and spleen, erosion of long bones, mental retardation in infants</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>7</p>\n</td>\n<td>\n<p>Niemann–Pick disease</p>\n</td>\n<td>\n<p>Sphingomyelinase</p>\n</td>\n<td>\n<p>Sphingomyelin</p>\n</td>\n<td>\n<p>Enlarged liver and spleen, mental retardation; fatal in early life</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>8</p>\n</td>\n<td>\n<p>Farber's disease</p>\n</td>\n<td>\n<p>Ceramidase</p>\n</td>\n<td>\n<p>Ceramide</p>\n</td>\n<td>\n<p>Hoarseness, dermatitis, skeletal deformation, mental retardation; fatal in early life</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9621",
      "difficulty": "easy"
    }
  ]
}